Market Cap (In CAD)
74.82 Million
Revenue (In CAD)
-
Net Income (In CAD)
-38.99 Million
Avg. Volume
224.05 Thousand
- Currency
- CAD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.2-0.73
- PE
- -
- EPS
- -
- Beta Value
- 1.316
- ISIN
- CA81732W1041
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Ms. Cynthia Pussinen
- Employee Count
- -
- Website
- https://www.sernova.com
- Ipo Date
- 1999-04-29
- Details
- Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection. Its Cell Pouch is a medical device designed to create a vascularized tissue environment for the transplantation and engraftment of therapeutic cells, which then release proteins and/or hormones for the long-term treatment of various serious chronic diseases, such as diabetes, hemophilia, and thyroid disease. Sernova Corp. has a research collaboration with AgeX Therapeutics, Inc. to generate immune-protected therapeutic cells; and a research agreement with the University of Miami to advance the development of Cell Pouch cell therapy platform. The company was incorporated in 1998 and is headquartered in London, Canada.
More Stocks
-
000793Huawen Media Group
000793
-
0OQ0
-
002510Tianjin Motor Dies Co.,Ltd.
002510
-
9508
-
0704
-
SPODSpod Lithium Corp.
SPOD
-
CKOCFChudenko Corporation
CKOCF
-
2CUREX2cureX AB (publ)
2CUREX